S&P 500 7,663.43 −1.21%
Nasdaq 26,008.86 −2.60%
S&P/TSX 35,973.45 −0.97%
Apple 348.22 +1.23%
Nvidia 212.21 −4.40%
Microsoft 521.08 −2.23%
Shopify 236.41 −3.48%
Royal Bank 282.78 −0.30%
CAD/USD 0.7142 +0.29%
AFTER HRS · 19:30 ET
Market ClerkRecap
Thu Oct 22 · after hours6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

NBIX

NEUROCRINE BIOSCIENCES INC
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
143.25
+1.94 +1.37%
USD · close Oct 22

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $14.6BP/E 21.0DIV YIELD —FCF YIELD 5.98%REV TTM $3.4B +34.4%NET INCOME $705.5M +102.6%NET CASH —52W 123.10 – 185.50SEC XBRL · TTM TO Invalid Date

Insider trading

SEC FORM 4 · OPEN-MARKET ONLY
−$826K
Net, 90 days
0 / 3
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
TradedFiledInsiderTypeSharesPriceValue
Sep 14Sep 15Boyer David W. · Chief Corp. Affairs OfficerSell826$157.45$130K
Sep 14Sep 15ABERNETHY MATT · Chief Financial OfficerSell2,311$157.20$363K
Sep 9Sep 10BENEVICH ERIC · Chief Commercial OfficerSell2,154$154.61$333K

Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.

Watch NBIX. Know when insiders buy.
One email the day a filing lands. Free.